Vaxart, Inc.
VXRT· OTC
Filed Nov 12, 2013 · 10-Q · 43 days after period end · 0001437749-13-014337
| Metric | Q1 2014 | Q1 2011 |
|---|---|---|
| Revenue | $12.20M | $9.17M |
| Net Income | -$3.90M | $1.98M |
| EPS Diluted | -$0.15 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end